Compound Detail
CHEMBL911
ZOLPIDEM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL911 |
| Name | ZOLPIDEM |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | ZAFYATHCZYHLPB-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
22
Targets
99
Activities
4
Assay Types
12
PK Parameters
20
Publications
3
Known Names
15
Indications
Molecular Properties
307.4
MW (Da)
3.25
ALogP
3
HBA
0
HBD
37.6
PSA (Ų)
0.74
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1992 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Anxiety Attention Deficit Disorder with Hyperactivity Dementia Depressive Disorder Schizophrenia Sleep Initiation and Maintenance Disorders Sleep Wake Disorders Autistic Disorder Parkinson Disease Substance-Related Disorders Dystonic Disorders Low Back Pain Marijuana Abuse Obesity Prostatic Neoplasms
ATC Classification
N05CF02
zolpidem
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS
Activity Summary
Ki 83 meas. best 7.81
EC50 10 meas. best 6.75
IC50 5 meas. best 7.85
Kd 1 meas. best 4.2
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Gamma-aminobutyric acid receptor subunit alpha-1 CHEMBL1962 | IC50 | 7.85 | 7.37 | 14.0 | 2 |
| Unchecked CHEMBL612545 | Ki | 7.81 | 6.9167 | 15.5 | 30 |
| GABA-A receptor; alpha-1/beta-2/gamma-2 CHEMBL2095167 | Ki | 7.72 | 7.42 | 19.0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-1 CHEMBL1962 | Ki | 7.7 | 7.455 | 20.0 | 2 |
| GABA-A receptor; anion channel CHEMBL1907607 | Ki | 7.6 | 7.46 | 25.0 | 2 |
| GABA-A receptor; alpha-1/beta-3/gamma-2 CHEMBL2094121 | Ki | 7.57 | 7.5286 | 26.7 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-1 CHEMBL343 | Ki | 7.57 | 7.57 | 26.7 | 1 |
| GABA A receptor alpha-5/beta-3/gamma-2 CHEMBL2111374 | Ki | 7.46 | 7.46 | 35.0 | 1 |
| GABA-A receptor; alpha-1/beta-2/gamma-2 CHEMBL2095172 | IC50 | 7.33 | 7.33 | 46.3 | 1 |
| GABA-A receptor; anion channel CHEMBL1907607 | IC50 | 7.32 | 7.32 | 48.0 | 1 |
| GABA A receptor alpha-1/beta-1/gamma-2 CHEMBL2111392 | Ki | 7.28 | 7.28 | 53.0 | 1 |
| GABA-A receptor; alpha-2/beta-3/gamma-2 CHEMBL2094130 | Ki | 6.99 | 6.8014 | 103.0 | 7 |
| GABA A receptor alpha-2/beta-2/gamma-2 CHEMBL2111327 | Ki | 6.81 | 6.2925 | 156.0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-2 CHEMBL341 | Ki | 6.81 | 6.465 | 156.0 | 2 |
| GABA A receptor alpha-2/beta-2/gamma-2 CHEMBL2111413 | EC50 | 6.75 | 6.75 | 180.0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 CHEMBL1962 | EC50 | 6.72 | 6.71 | 191.0 | 2 |
| GABA-A receptor; alpha-1/beta-2/gamma-2 CHEMBL2095172 | EC50 | 6.62 | 6.62 | 240.0 | 1 |
| GABA-A receptor; alpha-3/beta-3/gamma-2 CHEMBL2094120 | Ki | 6.61 | 6.4186 | 246.0 | 7 |
| Unchecked CHEMBL612545 | EC50 | 6.47 | 6.002 | 340.0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 CHEMBL328 | Ki | 6.42 | 6.42 | 383.0 | 1 |
| GABA A receptor alpha-3/beta-2/gamma-2 CHEMBL2111343 | Ki | 6.42 | 6.34 | 383.0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 CHEMBL3026 | Ki | 6.4 | 6.4 | 400.0 | 1 |
| GABA A receptor alpha-2/beta-2/gamma-2 CHEMBL2111413 | Ki | 6.39 | 6.39 | 408.0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 CHEMBL4956 | EC50 | 6.13 | 6.13 | 737.0 | 1 |
| GABA A receptor alpha-6/beta-2/gamma-2 CHEMBL2111365 | Ki | 6.01 | 5.93 | 980.0 | 2 |
| GABA A receptor alpha-3/beta-2/gamma-2 CHEMBL2111339 | Ki | 6.01 | 5.87 | 975.0 | 2 |
| Translocator protein CHEMBL4552 | IC50 | 5.33 | 5.33 | 4700.0 | 1 |
| Albumin CHEMBL3253 | Kd | 4.2 | 4.2 | 63000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 4.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | - | - | Rattus norvegicus |
| CL | 4.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 4.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 4.3 | mL.min-1.kg-1 | Homo sapiens |
| F | 72.0 | % | Homo sapiens |
| Fu | 0.08 | - | Homo sapiens |
| Fu | 0.08 | - | Homo sapiens |
| MRT | 2.1 | hr | Homo sapiens |
| T1/2 | 1.7 | hr | Homo sapiens |
| T1/2 | 2.0 | hr | Homo sapiens |
| T1/2 | 1.4 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine